On Friday, Structure Therapeutics Inc ADR (NASDAQ: GPCR) opened higher 8.58% from the last session, before settling in for the closing price of $18.53. Price fluctuations for GPCR have ranged from $13.22 to $45.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -51.75% over the last five years. Company’s average yearly earnings per share was noted -60.84% at the time writing. With a float of $54.38 million, this company’s outstanding shares have now reached $57.57 million.
The firm has a total of 163 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Structure Therapeutics Inc ADR (GPCR) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Structure Therapeutics Inc ADR is 4.58%, while institutional ownership is 90.26%.
Structure Therapeutics Inc ADR (GPCR) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.2 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.19) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -60.84% per share during the next fiscal year.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Trading Performance Indicators
Check out the current performance indicators for Structure Therapeutics Inc ADR (GPCR). In the past quarter, the stock posted a quick ratio of 20.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.13, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.72 in one year’s time.
Technical Analysis of Structure Therapeutics Inc ADR (GPCR)
Analysing the last 5-days average volume posted by the [Structure Therapeutics Inc ADR, GPCR], we can find that recorded value of 0.95 million was better than the volume posted last year of 0.88 million. As of the previous 9 days, the stock’s Stochastic %D was 87.04%.
During the past 100 days, Structure Therapeutics Inc ADR’s (GPCR) raw stochastic average was set at 44.63%, which indicates a significant decrease from 94.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.04 in the past 14 days, which was lower than the 1.37 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $19.50, while its 200-day Moving Average is $24.81. Now, the first resistance to watch is $20.80. This is followed by the second major resistance level at $21.48. The third major resistance level sits at $22.60. If the price goes on to break the first support level at $19.00, it is likely to go to the next support level at $17.88. Should the price break the second support level, the third support level stands at $17.20.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Key Stats
There are currently 57,598K shares outstanding in the company with a market cap of 1.16 billion. Presently, the company’s annual sales total 0 K according to its annual income of -122,530 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -61,660 K.
